×

Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Drugs and Devices

On March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression. Zulresso will be available only through a restricted program that requires the drug be administered by a healthcare provider in a certified health care facility.

Read more at FDA.gov . . .

Having a family member with persistent opioid use may be a risk factor for young adults (aged 13 to 21 years) continuing prescriptions long after their own surgeries, according to a study in JAMA Surgery.

Read more via Michigan Medicine Health Lab . . .

On Feb. 14, the FDA approved Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2). This new type of insulin pump, referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin pump, is the first interoperable pump, meaning it can be . . .

According to a Feb. 11 statement by the FDA, about 4.9 million middle and high school students had used were current users (used in the past 30 days) of some type of tobacco product in 2018, up from 3.6 million in 2017. A surge in e-cigarette use . . .

On Feb. 6, the FDA approved Cablivi (caplacizumab-yhdp) injection, the first therapy indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP).

Read more via U.S. Food & Drug Administration . . .

On December 21, 2018, the FDA approved the Miris Human Milk Analyzer, a new diagnostic test to help clinicians measure nutrients in breast milk, including the concentration of fat, carbohydrate, protein, total solids and energy.

Read more via U.S. Food & Drug Administration . . .

On Dec. 21, the FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria and approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm.

Read more via U.S. Food & Drug Administration news release 1 and news release 2 . . .

Researchers have identified a technique to determining which patients with a genetic mutation that cause long QT Syndrome type 3 will benefit from mexiletine.

Read more via theSource and Circulation Research . . .

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing